Emmessar Biotech & Nutrition Limited

Company Profile

Emmessar Biotech & Nutrition Limited had its IPO on under the ticker symbol 524768.

The company operates in the Other sector and Other industry. Emmessar Biotech & Nutrition Limited has a staff strength of 0 employees.

Stock update

Shares of Emmessar Biotech & Nutrition Limited opened at ₹24.02 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹24.02 - ₹26.12, and closed at ₹24.85.

This is a -1.82% slip from the previous day's closing price.

A total volume of 2,457 shares were traded at the close of the day’s session.

In the last one week, shares of Emmessar Biotech & Nutrition Limited have slipped by -7.62%.

Emmessar Biotech & Nutrition Limited's Key Ratios

Emmessar Biotech & Nutrition Limited has a market cap of ₹71.19 million, indicating a price to book ratio of 1.7969 and a price to sales ratio of 4.2713.

In the last 12-months Emmessar Biotech & Nutrition Limited’s revenue was ₹30.00 million with a gross profit of ₹32.08 million and an EBITDA of ₹5.72 million. The EBITDA ratio measures Emmessar Biotech & Nutrition Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Emmessar Biotech & Nutrition Limited’s operating margin was 17.31% while its return on assets stood at 0% with a return of equity of 0%.

In Q2, Emmessar Biotech & Nutrition Limited’s quarterly earnings growth was a negative -92.5% while revenue growth was a negative 78.3%.

Emmessar Biotech & Nutrition Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

19.9091

PEG

Its diluted EPS in the last 12-months stands at ₹0.766 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Emmessar Biotech & Nutrition Limited’s profitability.

Emmessar Biotech & Nutrition Limited stock is trading at a EV to sales ratio of 3.2016 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 4.2713.

Emmessar Biotech & Nutrition Limited stock pays annual dividends of ₹ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹0

Total Liabilities

₹0

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

Emmessar Biotech & Nutrition Limited ended 2024 with ₹0 in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹0 while shareholder equity stood at ₹0.

Emmessar Biotech & Nutrition Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹0 in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

Emmessar Biotech & Nutrition Limited’s total current assets stands at ₹0 while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹0 compared to accounts payable of ₹0 and inventory worth ₹0.

In 2024, Emmessar Biotech & Nutrition Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, Emmessar Biotech & Nutrition Limited paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹24.85

52-Week High

₹33.95

52-Week Low

₹18.5

Analyst Target Price

₹

Emmessar Biotech & Nutrition Limited stock is currently trading at ₹24.85 per share. It touched a 52-week high of ₹33.95 and a 52-week low of ₹33.95. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹24.83 and 200-day moving average was ₹25.33 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 5946.3% of the company’s stock are held by insiders while 0% are held by institutions.